These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31580769)

  • 1. Pembrolizumab and Severe Hypertriglyceridemia Requiring Apheresis: An Immune-Related Adverse Event.
    Thakker M; Quadri K; Desai A; Illyas W; Kim MY; Desai S; Rager C
    J Oncol Pract; 2019 Nov; 15(11):613-614. PubMed ID: 31580769
    [No Abstract]   [Full Text] [Related]  

  • 2. Tracheoesophageal Fistula Caused by Successful Response to Pembrolizumab in a Patient With Squamous Cell Lung Cancer.
    Wang H; Zhang L; Liu W
    J Thorac Oncol; 2019 Jul; 14(7):e141-e143. PubMed ID: 31235036
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokine Release Syndrome with Pseudoprogression in a Patient with Advanced Non-Small Cell Lung Cancer Treated with Pembrolizumab.
    Kogure Y; Ishii Y; Oki M
    J Thorac Oncol; 2019 Mar; 14(3):e55-e57. PubMed ID: 30782385
    [No Abstract]   [Full Text] [Related]  

  • 4. Susac's syndrome as an immune-related adverse event after pembrolizumab: a case report.
    De Groot M; Compter A; De Langen AJ; Brandsma D
    J Neurol; 2020 Jan; 267(1):282-284. PubMed ID: 31701330
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute pancreatitis associated with pembrolizumab-induced hypertriglyceridemia.
    Inayat F; Afzal A; Anwar MS; Saeed A; Chaudhry A; Haider M; Zulfiqar L; Afzal MS; Arslan HM; Saif MW
    J Oncol Pharm Pract; 2024 Sep; 30(6):1101-1110. PubMed ID: 38576329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Experience With Pembrolizumab in Patients With Advanced Lung Cancer.
    Peng TR; Wu TW
    Am J Ther; 2019; 26(4):e537-e538. PubMed ID: 30946046
    [No Abstract]   [Full Text] [Related]  

  • 7. Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab.
    Hsu CL; Chen KY; Kuo SW; Chang YL
    J Thorac Oncol; 2017 Jun; 12(6):e75-e76. PubMed ID: 28532567
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal encephalopathy after pembrolizumab treatment for advanced non-small cell lung carcinoma.
    Freitas C; Sampaio L; Fernandes G
    J Neurooncol; 2019 Nov; 145(2):399-402. PubMed ID: 31506753
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune-Related Primary Hypoparathyroidism Possibly Induced by the Administration of Pembrolizumab: A Case Report.
    Umeguchi H; Takenoshita H; Inoue H; Kurihara Y; Sakaguchi C; Yano S; Hasuzawa N; Sakamoto S; Sakamoto R; Ashida K
    J Oncol Pract; 2018 Jul; 14(7):449-451. PubMed ID: 29906213
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer.
    Romeo MAL; Garassino MC; Moiola L; Galli G; Comi G; Martinelli V; Filippi M
    J Neurol; 2019 Dec; 266(12):3163-3166. PubMed ID: 31586260
    [No Abstract]   [Full Text] [Related]  

  • 11. Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy.
    Andersson NW; Zachariae C; Simonsen AB
    Eur J Cancer; 2021 Mar; 145():168-170. PubMed ID: 33486439
    [No Abstract]   [Full Text] [Related]  

  • 12. Pembrolizumab-Related Enophthalmos.
    Manta A; Goldberg RA
    Ophthalmology; 2020 Jan; 127(1):121. PubMed ID: 31864472
    [No Abstract]   [Full Text] [Related]  

  • 13. Pembrolizumab-induced obstructive bronchiolitis in a patient with stage IV non-small-cell lung cancer.
    Blanchard A; Bouchard N
    Curr Oncol; 2019 Aug; 26(4):e571-e573. PubMed ID: 31548826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prurigo nodularis and pembrolizumab: A therapeutic challenge.
    Fattore D; Panariello L; Annunziata MC; Fabbrocini G
    Eur J Cancer; 2019 Mar; 110():8-10. PubMed ID: 30735833
    [No Abstract]   [Full Text] [Related]  

  • 15. In regard to Rosenzweiz et al. IJROBP 2001;50:681-685.
    Jenkins P
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):878. PubMed ID: 11849815
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of non-small cell lung cancer with danazol-dependent aplastic anemia induced by pembrolizumab.
    Goda S; Tsuji T; Matsumoto Y; Shiotsu S; Tanaka S; Suga Y; Fujii H; Matsuyama A; Omura A; Yuba T; Takumi C; Hiraoka N
    Curr Probl Cancer; 2021 Jun; 45(3):100686. PubMed ID: 33293197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unknown reaction to pembrolizumab: giant cell arteritis.
    Micaily I; Chernoff M
    Ann Oncol; 2017 Oct; 28(10):2621-2622. PubMed ID: 28633343
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring.
    Katsume Y; Isawa T; Toi Y; Fukuda R; Kondo Y; Sugawara S; Ootomo T
    Intern Med; 2018 Nov; 57(21):3157-3162. PubMed ID: 29877257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the humeral head in a patient with non-small cell lung cancer receiving bevacizumab.
    Koczywas M; Cristea MC
    J Thorac Oncol; 2011 Nov; 6(11):1960-1. PubMed ID: 22005475
    [No Abstract]   [Full Text] [Related]  

  • 20. Durable Response After 2 Doses of Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer With an Isolated Brain Metastasis.
    Uprety D; Arjyal L; Vallatharasu Y; Bista A; Wittchow RJ; Marinier DE
    Clin Lung Cancer; 2019 Sep; 20(5):e552-e554. PubMed ID: 31285178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.